Avistone Pharmaceuticals is based in Beijing, China. It has raised $340M in total funding. Latest round: Series A.
Avistone Pharmaceuticals is based in Beijing, China. Avistone Pharmaceuticals has raised $340M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Avistone Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Vivo Capital, Bain Capital, Primavera Capital. 3 distinct backers are named across the disclosed rounds.
Round data for Avistone Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Beijing and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026